Rho
↗Durham, North Carolina, USA
Rho is a full-service contract research organization (CRO) that provides a comprehensive suite of clinical development services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1984, the company specializes in guiding clients through program strategies, clinical trial design, and the complex regulatory submission process to accelerate time to market.
Rho is known for its 'Cohesion Effect' philosophy, emphasizing strong partnerships between sponsors, investigators, and sites. The company has a significant track record in managing federally funded research, including long-standing contracts with the NIH and BARDA, and is a key player in infectious disease, neurology, and respiratory research.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Contract Research Organization (CRO)
SIZE & FINANCIALS
Employees:501-1000
Revenue:$36M-$80M
Founded:1984
Ownership:private
Status:operating
FUNDING
Stage:Grant
Total Raised:$0.4M
Investors:Public Health Emergency, NIH, BARDA
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 3 / NDA Support
Modalities:Small molecule, Biologics, Vaccines, Medical Devices
Active Trials:23
Trial Phases:Phase 1: 5 | Phase 2: 8 | Phase 3: 6 | Phase 4: 4
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Dokumeds (Acquired 2021)
Key Partnerships:NIH-NIAID (Autoimmune disease research), BARDA (Avian Influenza and COVID-19 vaccines), Tonix Pharmaceuticals (Fibromyalgia NDA support), First Wave BioPharma (Cystic fibrosis trials), Sharp Therapeutics Corp (Gaucher Disease trials)
COMPETITION
Position:Niche Player
Competitors:Syneos Health, Emmes, TFS HealthScience, CTI Clinical Trial and Consulting, Clario, ICON, Parexel
LEADERSHIP
Key Executives:
Laura Helms Reece - CEO
Peter Schmidt - SVP, Global Partnerships
Andrew Feigin - Chief Medical Officer
Mark Ubert - CFO
Board Members:Laura Helms Reece
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Rho. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.